skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 1 more answer this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I have been holding BIIB for a couple of years on hopes (I know, that is not an investment strategy) that their alzheimer drug would be approved. It has come close a few times and the stock has reacted very favourably only to fall short of approval and fall back in price. Do you believe that the recent setback will make BIIB dead money for the foreseeable future and its best to move on or is it too cheap and compelling a story to sell now? If BIIB was part of your US Growth portfolio would you keep it or sell in favour of a better growth stock. If your decision would be to sell, what would be the top 2 names for replacement with no regard to sector.

Thanks
Scott
Read Answer Asked by Scott on November 19, 2020
Q: Hi 5i,
In their latest quarter results, they did beat the estimates. Remdesivir is still a one of the most used drug treatment. My opinion is that it will still be continued to be used for treatment till a better one is found.
Not sure why market is not so excited about the results and future prospects. Can you clarify.
Thanks for your sound advise.
Read Answer Asked by Vinod on November 17, 2020
Q: I am interested why you would recommend Cloud MD (Doc). Is it because it's share price has increased by the graces of companies like Teladoc and Well, or do you think their promotional approach will result in a successful business model? I am old enough to remember Patient Home Monitoring (phm). Similarities here?
Read Answer Asked by Rashida on November 16, 2020
Q: I do not have any Health Care and am looking for an ETF. What is your opinion of ZUH.CA. How would you rate the BMO ETF's? What other two Health Care ETF's should be considered.
Thank you.
Read Answer Asked by Nadine on November 13, 2020
Q: I am looking to add more healthcare to my portfolio - thinking about adding Pfizer plus an ETF. Given the recent vaccine news I am surprised that the price of PFE has not really soared. Can you shed some light on this? Do you feel PFE has upside growth potential - is it a good buy at the current prices? Patrick
Read Answer Asked by Patrick on November 12, 2020
Q: Can I get your thoughts on PSNL please, it's gotten some attention now that ARK has disclosed they own 10.1%. Is this company good enough for a starter position?
Read Answer Asked by dan on November 12, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!